POET Technologies: A Photonics Pioneer's Credibility Crisis Deepens After Marvell Cancellation
Published on 07/28/2026 at 04:42 | Redaktion boerse-global.de
The story of POET Technologies has always been one of promise over proof. But in recent weeks, that promise has been battered by a series of blows that go far beyond the usual volatility of a pre-revenue tech stock. What began as a steep correction from May's highs has metastasized into a full-blown crisis of confidence, triggered by a cancelled order from a key customer and compounded by allegations that strike at the heart of management's credibility.
The Celestial AI Bombshell
On April 27, 2026, the narrative around POET shifted dramatically. The company's stock plunged 47% in a single session after the Celestial AI unit of Marvell Technologies cancelled all outstanding orders, citing an alleged breach of confidentiality. The accusation was specific: a senior POET manager, identified in court filings as the CFO, reportedly violated a non-disclosure agreement during a public interview. That breach, according to Celestial AI, was the basis for terminating the relationship.
The market's reaction was brutal and immediate. From a 52-week high of €18.84 reached in May, the stock has now fallen 68.37%. The 30-day decline stands at 27.85%, with the shares trading at €5.96 as of Monday — a further 2.13% drop. Even the broader six-month picture offers little comfort: the stock is down 66.83% from its peak, and the 12-month gain has shrunk to just 17.79%.
Legal Fallout Piles On
The Celestial AI cancellation was only the opening act. Multiple law firms have now filed a class action lawsuit alleging securities fraud, and the accusations extend well beyond a single lost customer.
Should investors sell immediately? Or is it worth buying POET Technologies?
The complaints center on two main issues. First, POET is accused of misrepresenting its US tax status. Investors were allegedly not warned that the company could be classified as a Passive Foreign Investment Company (PFIC), which carries significant tax consequences for US shareholders. The relevant class period runs from April 1 to April 27, 2026 — a narrow window that suggests prosecutors believe the problem was acute and recent.
Second, and more damaging, is the confidentiality breach allegation itself. The claim that a senior executive disclosed proprietary information in a public setting has cast a shadow over all previous management statements about the company's business outlook and customer relationships. For institutional investors, this is the kind of reputational stain that can take months — or longer — to erase.
A Balance Sheet That Buys Time
Despite the turmoil, POET is not without resources. The company maintains a solid cash position with minimal debt, giving it financial breathing room to navigate the current storm. That's no small advantage for a pre-revenue semiconductor story facing litigation.
The commercial pipeline also still holds potential. POET has a supply agreement with Lumilens that includes an initial order worth $50 million for EOI-based optical engines, with a framework that could reach over $500 million across five years. And management continues to affirm its production timeline: optical engine manufacturing is slated to ramp in the second half of 2026, targeting capacity of up to one million units per month by the end of 2027.
The underlying thesis — that photonic interconnects will be essential for next-generation data centers — remains intact. Global demand for AI infrastructure continues to grow, with regions like Southeast Asia investing heavily. Malaysia's export growth is projected at 15.8% in 2026, driven partly by data center buildout. POET's technology addresses a real bottleneck in power and heat management for high-performance computing.
Technical Signals Point Lower
The chart tells a story of unresolved selling pressure. The stock now trades 12.90% below its 200-day moving average of €6.84 — a level that previously served as support and has now flipped to resistance. The relative strength index sits at 35.5, approaching oversold territory but not yet there, leaving room for further downside.
Annualized 30-day volatility stands at 90.90%, a figure that rivals biotech stocks rather than established semiconductor companies. The 50-day moving average is well below the 200-day, confirming a bearish short-term trend that has yet to find a floor. The 52-week low of €3.40 serves as a reminder of how far the stock could fall if the legal and operational headwinds intensify.
POET Technologies at a turning point? This analysis reveals what investors need to know now.
The Revenue Reality Check
POET's financials underscore the gap between valuation and execution. The company reported 2025 revenue of $1.07 million — a staggering 2,494.60% increase from the prior year, but still a trivial sum for a company with a market capitalization of €416.97 million. Growth from a near-zero base is easy to achieve but says little about the path to commercial viability.
The stock's annualized volatility of 91.83% reflects the binary nature of the bet: either POET executes on its production ramp and justifies its premium, or it doesn't, and the downside is severe. The recent sell-off in other networking and optics names — NetScout and Viavi Solutions have also retreated from their AI-infrastructure highs — suggests the sector is repricing the costs and timelines involved.
What Comes Next
For now, the balance sheet provides a cushion, but the legal overhang is the dominant factor. Until the class action is resolved or POET can demonstrate that the production ramp in Malaysia is translating into qualified revenue, the stock remains a high-risk wager on a technology that works — but a company whose credibility is under question.
The distance from the current price to the 52-week low — still 75.29% above it — suggests some investors are already positioning for a rebound. But calling a durable bottom while the legal risk remains unresolved looks premature. POET's growth story reads well on paper, but the combination of a cancelled order, a confidentiality breach allegation, and a tax classification dispute has turned what was once a bet on technology into a bet on management's ability to restore trust. Until that happens, the stock belongs on a watchlist, not in a portfolio.
Ad
POET Technologies Stock: New Analysis - 28 July
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
